tiprankstipranks
Advertisement
Advertisement
Six new option listings on May 13th
PremiumThe FlySix new option listings on May 13th
2M ago
X4 Pharmaceuticals Shareholders Approve Expanded Equity Incentive Plan
Premium
Company Announcements
X4 Pharmaceuticals Shareholders Approve Expanded Equity Incentive Plan
2M ago
X4 Pharmaceuticals reports Q1 EPS (16c), consensus (20c)
Premium
The Fly
X4 Pharmaceuticals reports Q1 EPS (16c), consensus (20c)
2M ago
X4 Pharmaceuticals (XFOR) Q4 Earnings Cheat Sheet
PremiumPre-EarningsX4 Pharmaceuticals (XFOR) Q4 Earnings Cheat Sheet
4M ago
X4 Pharmaceuticals initiated with a Buy at Guggenheim
Premium
The Fly
X4 Pharmaceuticals initiated with a Buy at Guggenheim
4M ago
X4 Pharmaceuticals receives positive CHMP opinion for mavorixafor
Premium
The Fly
X4 Pharmaceuticals receives positive CHMP opinion for mavorixafor
4M ago
X4 Pharmaceuticals price target lowered to $7.50 from $9 at Stifel
PremiumThe FlyX4 Pharmaceuticals price target lowered to $7.50 from $9 at Stifel
8M ago
X4 Pharmaceuticals reports Q3 EPS (69c), consensus (84c)
Premium
The Fly
X4 Pharmaceuticals reports Q3 EPS (69c), consensus (84c)
8M ago
X4 Pharmaceuticals 45.87M share Spot Secondary priced at $2.85
Premium
The Fly
X4 Pharmaceuticals 45.87M share Spot Secondary priced at $2.85
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100